Impact of fixed-dose combination of isosorbide dinitrate and hydralazine on heart failure progression in an African American population: Focus on mode of death and hospitalization

被引：0

作者：

Carson, Peter

Anand, Inder

Ghali, Jalal K.

Lindenfeld, JoAnn

Miller, Alan B.

Tristani, Felix

Braman, Virginia M.

Worcel, Manuel

Sabolinski, Michael L.

机构：

[1] Vet Affairs Med Ctr, Washington, DC 20422 USA

[2] Vet Affairs Med Ctr, Minneapolis, MN USA

[3] Wayne State Univ, Detroit, MI USA

[4] Univ Colorado, Denver, CO 80202 USA

[5] Univ Florida, Jacksonville, FL USA

[6] NitroMed Inc, Lexington, MA USA

来源：

CIRCULATION | 2006年 / 114卷 / 18期

关键词：

D O I：

暂无

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

引用

页码：572 / 572

页数：1

共 47 条

[31] Isosorbide dinitrate and hydralazine in a fixed-dose combination produces further regression of left ventricular remodeling in a well-treated black population with heart failure: Results from A-HeFT
Cohn, Jay N.
Tam, William
Anand, Inder S.
Taylor, Anne L.
Sabolfnski, Michael L.
Worcel, Manuel
JOURNAL OF CARDIAC FAILURE, 2007, 13 (05) : 331 - 339
[32] Fixed combination isosorbide dinitrate-hydralazine for nitric-oxide-enhancing therapy in heart failure
Franciosa, Joseph A.
EXPERT OPINION ON PHARMACOTHERAPY, 2006, 7 (18) : 2521 - 2531
[33] Beta 1 adrenergic receptor Gly389Arg polymorphism and the impact of fixed-dose combination of isosorbide dinitrate/hydralazine in heart failure: Results from the A-HeFT trial
McNamara, DM
Tam, SW
Sabolinski, ML
Tobelman, P
Palmer, A
Janosko, K
Feldman, AM
Worcel, M
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2006, 47 (04) : 67A - 67A
[34] Editorial commentary on fixed combination isosorbide dinitrate/hydralazine for nitric-oxide-enhancing therapy in heart failure
Flack, John M.
EXPERT OPINION ON PHARMACOTHERAPY, 2007, 8 (03) : 275 - 277
[35] Use of Isosorbide Dinitrate and Hydralazine in African-Americans With Heart Failure 9 Years After the African-American Heart Failure Trial
Ferdinand, Keith Copelin
Elkayam, Uri
Mancini, Donna
Ofili, Elizabeth
Pina, Ileana
Anand, Inder
Feldman, Arthur Michael
McNamara, Dennis
Leggett, Christopher
AMERICAN JOURNAL OF CARDIOLOGY, 2014, 114 (01): : 151 - 159
[36] Interpreting the African American Heart Failure Trial (A-HeFT) - Isosorbide dinitrate-hydralazine improves outcomes in African Americans with heart failure
Colvin-Adams, Monica
Taylor, Anne L.
CLEVELAND CLINIC JOURNAL OF MEDICINE, 2007, 74 (03) : 227 - 234
[37] Fixed-Dose Versus Off-Label Combination of Isosorbide Dinitrate Plus Hydralazine Hydrochloride: Retrospective Propensity-Matched Analysis in Black Medicare Patients with Heart Failure
Elizabeth Ofili
Inder Anand
Richard Allen Williams
Ola Akinboboye
Liou Xu
Gary Puckrein
Advances in Therapy, 2017, 34 : 1976 - 1988
[38] Fixed-Dose Versus Off-Label Combination of Isosorbide Dinitrate Plus Hydralazine Hydrochloride: Retrospective Propensity-Matched Analysis in Black Medicare Patients with Heart Failure
Ofili, Elizabeth
Anand, Inder
Williams, Richard Allen
Akinboboye, Ola
Xu, Liou
Puckrein, Gary
ADVANCES IN THERAPY, 2017, 34 (08) : 1976 - 1988
[39] Administration of fixed-dose combination of isosorbide dinitrate (ISDN) and hydralazine (HYD) is associated with improved outcomes in post-menopausal women
Lindenfeld, JoAnn
Taylor, Anne L.
Braman, Virginia M.
Walsh, Mary N.
Cohn, John N.
Sabolinski, Michael
JOURNAL OF CARDIAC FAILURE, 2006, 12 (06) : S86 - S86
[40] ARE BOTH HYDRALAZINE AND ISOSORBIDE DINITRATE NECESSARY TO PROVIDE A MORTALITY BENEFIT IN AFRICAN AMERICAN PATIENTS WITH SYSTOLIC HEART FAILURE?
Salamon, Jason N.
Mazurek, Jeremy
Zolty, Ronald
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2012, 59 (13) : E1034 - E1034

← 1 2 3 4 5 →